Accelerating corneal wound healing using exosome-mediated targeting of NF-κB c-Rel.
Corneal wound healing
Exosome
Inflammation
NF-κB
siRNA
Journal
Inflammation and regeneration
ISSN: 1880-9693
Titre abrégé: Inflamm Regen
Pays: England
ID NLM: 101479577
Informations de publication
Date de publication:
26 Jan 2023
26 Jan 2023
Historique:
received:
14
10
2022
accepted:
18
01
2023
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
27
1
2023
Statut:
epublish
Résumé
The integrity of the corneal epithelium is essential for the maintenance of the physiological function of the cornea. Studies have found that inflammation greatly delays corneal wound healing. NF-κB c-Rel is preferentially expressed by immune cells and promotes the expression of inflammatory cytokines. In the current study, we sought to investigate whether c-Rel could be used as a potential therapeutic target for treating a corneal injury. Our studies reveal that expressions of c-Rel and its inflammatory targets are significantly increased in the cornea of mice with corneal injury. In addition, we find that c-Rel-deficient mice exhibit accelerated corneal wound healing and reduced expression of inflammatory cytokines. Further studies show that topical treatment on the corneal surface using nano-polymers or exosomes loaded with c-Rel-specific siRNA (siRel) can effectively accelerate regular and diabetic corneal wound healing. More importantly, we find that exosomes, as carriers of siRel, showed better efficacy than nano-polymers in treating corneal injury. We further demonstrate that exosomes secreted by mesenchymal stem cells can efficiently transfer siRNA into macrophages and dendritic cells but not T cells. Taken together, these results indicate that blocking c-Rel may represent an attracting strategy for the treatment of both regular and diabetic corneal injury.
Identifiants
pubmed: 36703231
doi: 10.1186/s41232-023-00260-y
pii: 10.1186/s41232-023-00260-y
pmc: PMC9881367
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6Subventions
Organisme : Qingdao Science and Technology Bureau
ID : 21-1-4-rkjk-11-nsh
Organisme : National Natural Science Foundation of China
ID : 82271129
Organisme : National Natural Science Foundation of China
ID : 82201152
Organisme : Natural Science Foundation of Shandong Province
ID : ZR2021QH013
Organisme : Postdoctoral Innovation Project of Shandong Province
ID : 202103021
Informations de copyright
© 2023. The Author(s).
Références
Crit Rev Ther Drug Carrier Syst. 2021;38(6):49-103
pubmed: 34587429
J Exp Med. 2011 Oct 24;208(11):2321-33
pubmed: 22006976
Cornea. 2007 Oct;26(9 Suppl 1):S75-81
pubmed: 17881921
CNS Neurol Disord Drug Targets. 2019;18(1):3-10
pubmed: 28782486
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5194-5200
pubmed: 30372747
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3943-52
pubmed: 19324842
Adv Exp Med Biol. 2012;946:207-21
pubmed: 21948370
J Immunol. 2020 Apr 15;204(8):2053-2063
pubmed: 32169850
Biomed Res Int. 2022 Feb 21;2022:6600788
pubmed: 35237689
J Biotechnol. 2013 May 20;165(2):77-84
pubmed: 23562828
Sci China Life Sci. 2020 Apr;63(4):485-500
pubmed: 31054052
Acta Pharm Sin B. 2017 May;7(3):281-291
pubmed: 28540165
Stem Cells Transl Med. 2020 Mar;9(3):316-327
pubmed: 31802651
Metabolism. 2021 Jan;114:154402
pubmed: 33053398
Int Immunopharmacol. 2018 Mar;56:9-17
pubmed: 29324391
Drug Saf. 2002;25(4):233-50
pubmed: 11994027
Front Med (Lausanne). 2020 Sep 24;7:583691
pubmed: 33072790
Front Immunol. 2021 Nov 23;12:780897
pubmed: 34887868
Curr Opin Ophthalmol. 2004 Aug;15(4):311-5
pubmed: 15232470
Biomaterials. 2022 Jan;280:121320
pubmed: 34923312
Immunol Cell Biol. 2017 Aug;95(7):593-600
pubmed: 28202908
Clin Immunol. 2016 Apr;165:47-54
pubmed: 26993753
Top Companion Anim Med. 2015 Sep;30(3):74-80
pubmed: 26494498
Methods Mol Biol. 2021;2193:149-158
pubmed: 32808267
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Aust J Gen Pract. 2019 Aug;48(8):504-506
pubmed: 31370122
ACS Nano. 2017 Jul 25;11(7):6968-6976
pubmed: 28679045
PLoS One. 2011 Jan 31;6(1):e16712
pubmed: 21304961
Transl Res. 2019 Dec;214:62-91
pubmed: 31369717
Ophthalmology. 2009 Jun;116(6):1038-47
pubmed: 19394702
Genes Dev. 1995 Aug 15;9(16):1965-77
pubmed: 7649478
Immunol Rev. 2012 Mar;246(1):379-400
pubmed: 22435567
J Control Release. 2015 Dec 10;219:396-405
pubmed: 26241750
J Immunol. 2003 Nov 1;171(9):4886-92
pubmed: 14568969
ACS Appl Mater Interfaces. 2021 Apr 28;13(16):18472-18487
pubmed: 33856781
Cancer Gene Ther. 2016 Apr;23(4):73-82
pubmed: 26987292
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034
pubmed: 20066092
FASEB J. 2011 Aug;25(8):2659-68
pubmed: 21518851
Cornea. 2004 Nov;23(8 Suppl):S25-30
pubmed: 15448476
Int J Biochem Cell Biol. 2013 Nov;45(11):2580-4
pubmed: 24004831
Sci Rep. 2016 Nov 22;6:36905
pubmed: 27874029
Nanomaterials (Basel). 2017 Apr 05;7(4):
pubmed: 28379201
Cornea. 2009 Dec;28(10):1104-8
pubmed: 19730088
Ther Deliv. 2019 May 1;10(5):311-332
pubmed: 31116099